169 related articles for article (PubMed ID: 31381236)
1. A rat model of placental inflammation explains the unexplained elevated maternal serum alpha-fetoprotein associated with adverse pregnancy outcomes.
Hu J; Zhang J; Chan Y; Zhu B
J Obstet Gynaecol Res; 2019 Oct; 45(10):1980-1988. PubMed ID: 31381236
[TBL] [Abstract][Full Text] [Related]
2. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease.
Dinglas C; Afsar N; Cochrane E; Davis J; Kim S; Akerman M; Wells M; Chavez M; Herrera K; Heo H; Vintzileos A
Am J Obstet Gynecol; 2020 May; 222(5):499.e1-499.e6. PubMed ID: 31794723
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
4. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
5. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes.
Williams MA; Hickok DE; Zingheim RW; Luthy DA; Kimelman J; Nyberg DA; Mahony BS
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1032-7. PubMed ID: 1384333
[TBL] [Abstract][Full Text] [Related]
6. Placental and fetal membrane Nephrin and Neph1 gene expression: response to inflammation.
Beall MH; Amidi F; Gayle DA; Wang S; Beloosesky R; Ross MG
J Soc Gynecol Investig; 2005 Jul; 12(5):298-302. PubMed ID: 15979540
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes of women with elevated second-trimester maternal serum alpha-fetoprotein.
Hu JL; Zhang YJ; Zhang JM; Zhu S; Li DM; Yin YF; Su J; Chan Y; He J; Cao YJ; Zhu BS
Taiwan J Obstet Gynecol; 2020 Jan; 59(1):73-78. PubMed ID: 32039804
[TBL] [Abstract][Full Text] [Related]
8. Placental sonolucency and pregnancy outcome in women with elevated second trimester serum alpha-fetoprotein levels.
Kuo PL; Lin CC; Lin YH; Guo HR
J Formos Med Assoc; 2003 May; 102(5):319-25. PubMed ID: 12874670
[TBL] [Abstract][Full Text] [Related]
9. First-trimester maternal serum alpha-fetoprotein is not a good predictor for adverse pregnancy outcomes: a retrospective study of 3325 cases.
Hu J; Zhang J; He G; Zhu S; Tang X; Su J; Li Q; Kong Y; Zhu B
BMC Pregnancy Childbirth; 2020 Feb; 20(1):104. PubMed ID: 32050927
[TBL] [Abstract][Full Text] [Related]
10. Combined in utero hypoxia-ischemia and lipopolysaccharide administration in rats induces chorioamnionitis and a fetal inflammatory response syndrome.
Maxwell JR; Denson JL; Joste NE; Robinson S; Jantzie LL
Placenta; 2015 Dec; 36(12):1378-84. PubMed ID: 26601766
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies.
Jauniaux E; Gulbis B; Tunkel S; Ramsay B; Campbell S; Meuris S
Prenat Diagn; 1996 Dec; 16(12):1129-35. PubMed ID: 8994249
[TBL] [Abstract][Full Text] [Related]
12. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
13. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications.
Waller DK; Lustig LS; Cunningham GC; Feuchtbaum LB; Hook EB
Obstet Gynecol; 1996 Nov; 88(5):816-22. PubMed ID: 8885920
[TBL] [Abstract][Full Text] [Related]
14. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
Konchak PS; Bernstein IM; Capeless EL
Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
[TBL] [Abstract][Full Text] [Related]
15. Elevated midtrimester α-fetoprotein and delivery markers of inflammation in a preterm population.
Ho M; Faye-Petersen OM; Goldenberg RL; Carlo WA; Cliver SP; Andrews WW
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2424-7. PubMed ID: 22681575
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening.
Bartkute K; Balsyte D; Wisser J; Kurmanavicius J
J Perinat Med; 2017 Oct; 45(7):817-820. PubMed ID: 27771626
[TBL] [Abstract][Full Text] [Related]
17. Correlation between elevated maternal serum alpha-fetoprotein and ischemic placental disease: a retrospective cohort study.
Dai X; Zhang H; Wu B; Ning W; Chen Y; Chen Y
Clin Exp Hypertens; 2023 Dec; 45(1):2175848. PubMed ID: 36849437
[TBL] [Abstract][Full Text] [Related]
18. Maternal floor infarction of the placenta associated with elevated second trimester serum alpha-fetoprotein.
Katz VL; Bowes WA; Sierkh AE
Am J Perinatol; 1987 Jul; 4(3):225-8. PubMed ID: 2440457
[TBL] [Abstract][Full Text] [Related]
19. Raised maternal serum alpha-fetoprotein in the absence of fetal abnormality--placental findings. A quantitative morphometric study.
Boyd PA; Keeling JW
Prenat Diagn; 1986; 6(5):369-73. PubMed ID: 2430276
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of protective effects of maternal fingolimod on the placenta and fetal lung and brain in chorioamnionitis-induced preterm birth rat model.
Yavuz A; Sezik M; Eris Yalcin S; Asci H; Ozmen O
Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):564-571. PubMed ID: 32892670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
